1. Improved Treatment Results in Childhood B-Cell Neoplasms With Tailored Intensification of Therapy: A Report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90
by Alfred Reiter, Martin Schrappe, Markus Tiemann, Wolf-Dieter Ludwig, Elif Yakisan, Martin Zimmermann, Georg Mann, Andreas Chott, Wolfram Ebell, Thomas Klingebiel, Norbert Graf, Bernhard Kremens, Stefan Müller-Weihrich, Hans-Jürgen Plüss, Felix Zintl, Günter Henze, and Hansjörg Riehm
Blood
Volume 94(10):
November 15, 1999
©1999 by American Society of Hematology

2. Treatment strategy.
Treatment strategy. Patients were stratified into 3 risk groups: R1, R2, and R3. The composition of therapy courses is given in Table 1. V, cytoreductive prophase; CR, complete response; SL-OP, second-look operation; ABMT, autologous BMT or blood stem cell transplantation.
Alfred Reiter et al. Blood 1999;94:
©1999 by American Society of Hematology

3. Distribution of pretreatment serum LDH concentrations (logarithmic scale) according to stage of disease.
Distribution of pretreatment serum LDH concentrations (logarithmic scale) according to stage of disease. (○) Patients surviving event-free; (□) toxic death; (▴) patients suffering from progress; (*) patients who developed second malignancy. From 16 patyients (2, 7, 2, 1, and 4 of stage I, II, III, IV, and B-ALL, respectively) the LDH values are lacking. One of these patients (stage IV) relapsed, and 2 B-ALL patients died of acute cell lysis syndrome. One patient (stage III) with LDH less than 100 U/L and 3 patients (B-ALL) with LDH greater than 10,000 are not depicted; 1 of them (B-ALL) died of acute cell lysis syndrome.
Alfred Reiter et al. Blood 1999;94:
©1999 by American Society of Hematology

4. Alfred Reiter et al. Blood 1999;94:3294-3306
©1999 by American Society of Hematology

5. Alfred Reiter et al. Blood 1999;94:3294-3306
©1999 by American Society of Hematology

6. Kaplan-Meier estimate of EFS according to stage.
Kaplan-Meier estimate of EFS according to stage. SE, standard error.
Alfred Reiter et al. Blood 1999;94:
©1999 by American Society of Hematology

7. Alfred Reiter et al. Blood 1999;94:3294-3306
©1999 by American Society of Hematology

8. Alfred Reiter et al. Blood 1999;94:3294-3306
©1999 by American Society of Hematology

9. Kaplan-Meier estimate of EFS for patients with abdominal stage III B-NHL and LDH ≥500 U/L in trial NHL-BFM 90 and in the preceding trial NHL-BFM 86.
Kaplan-Meier estimate of EFS for patients with abdominal stage III B-NHL and LDH ≥500 U/L in trial NHL-BFM 90 and in the preceding trial NHL-BFM 86. SE, standard error.
Alfred Reiter et al. Blood 1999;94:
©1999 by American Society of Hematology